Mucosal haemangioma in the setting of treatment with trastuzumab emtansine (T-DM1)

被引：0
|
作者：
Belzer, Annika [1 ]
Silber, Andrea [2 ]
Mehra, Saral [3 ]
Gilani, Syed [4 ]
Leventhal, Jonathan S. [5 ]
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Yale Sch Med, Dept Med Oncol, New Haven, CT USA
[3] Yale Sch Med, Dept Otolaryngol, New Haven, CT USA
[4] Yale Sch Med, Dept Pathol, New Haven, CT USA
[5] Yale Sch Med, Dept Dermatol, New Haven, CT USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 187卷 / 05期
关键词：
D O I：
10.1111/bjd.21654
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E168 / E168
页数：1
相关论文
共 50 条
  • [1] Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment
    Arecco, Luca
    Blondeaux, Eva
    Damassi, Alessandra
    Fregatti, Piero
    Lambertini, Matteo
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (02) : 512 - 516
  • [2] Potential Mechanisms for Thrombocytopenia Development with Trastuzumab Emtansine (T-DM1)
    Uppal, Hirdesh
    Doudement, Estelle
    Mahapatra, Kaushiki
    Darbonne, Walter C.
    Bumbaca, Daniela
    Shen, Ben-Quan
    Du, Xiaoyan
    Saad, Ola
    Bowles, Kristin
    Olsen, Steve
    Phillips, Gail D. Lewis
    Hartley, Dylan
    Sliwkowski, Mark X.
    Girish, Sandhya
    Dambach, Donna
    Ramakrishnan, Vanitha
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (01) : 123 - 133
  • [3] Thrombokinetic studies of ado-trastuzumab emtansine (T-DM1)
    Gadi, V. K.
    Butler, B. S.
    Corson, J.
    Slichter, S. J.
    [J]. CANCER RESEARCH, 2016, 76
  • [4] Trastuzumab emtansine (T-DM1) for the treatment of HER2-positive breast cancer
    Sliwkowski, Mark X.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [5] Effect of trastuzumab emtansine (T-DM1) on autologous platelet kinetics.
    Gadi, Vijyakrishna
    Corson, Jill
    Cundy, Arianne
    Bailey, Shawn
    Pellham, Esther
    Christoffel, Todd
    Gettinger, Irena
    Barroso, Jeffrey
    Slichter, Sherrill
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Cardiotoxicity of trastuzumab emtansine (T-DM1): a single-center experience
    Acibuca, Aynur
    Sezer, Ahmet
    Yilmaz, Mustafa
    Sumbul, Ahmet Taner
    Demircan, Senol
    Muderrisoglu, Ibrahim Haldun
    Ozyilkan, Ozgur
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (12)
  • [7] Central neurotoxicity induced by trastuzumab emtansine (T-DM1): a case report
    Papageorgiou, Georgios I.
    Symeonidis, David G.
    Tsakatikas, Sergios A.
    Liatsos, Alexandros D.
    Douglas, Konstantinos A. A.
    Douglas, Vivian P.
    Moschos, Marilita M.
    Kosmas, Christos
    [J]. ANTI-CANCER DRUGS, 2021, 32 (10) : 1146 - 1149
  • [8] Activity of trastuzumab emtansine (T-DM1) in 3D cell culture
    Boyer, Jean Zheng
    Phillips, Gail D. Lewis
    Nitta, Hiro
    Garsha, Karl
    Admire, Brittany
    Kraft, Robert
    Dennis, Eslie
    Vela, Elizabeth
    Towne, Penny
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (01) : 65 - 75
  • [9] Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
    Diessner, J.
    Bruttel, V.
    Stein, R. G.
    Horn, E.
    Haeusler, S. F. M.
    Dietl, J.
    Hoenig, A.
    Wischhusen, J.
    [J]. CELL DEATH & DISEASE, 2014, 5 : e1149 - e1149
  • [10] Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
    J Diessner
    V Bruttel
    R G Stein
    E Horn
    S F M Häusler
    J Dietl
    A Hönig
    J Wischhusen
    [J]. Cell Death & Disease, 2014, 5 : e1149 - e1149
12345